Brought to you by 
BioMimetic nets $16.8mm in combined financing
09 Jul 2009
Executive Summary
BioMimetic Therapeutics (drug-device combo products for orthopedic indications) has completed an oversubscribed rights offering of 2mm shares at $8.50 (a 9% discount) to existing stockholders. In addition the company sold current backer Novo AS another 343k at the same price in a private placement. (Novo AS had been a standby purchaser in the rights offering but did not participate due to the oversubscription.) Total net proceeds from both transactions was $16.8mm.
Deal Industry
- Pharmaceuticals
-
Medical Devices
- Biomaterials
-
Biotechnology
- Large Molecule
Deal Status
- Final
Deal Type
-
Financing
- Other
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
BioMimetic nets $16.8mm in combined financing
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice